Quick Answer
Evofem Biosciences, Inc. reported Common Stock Shares Outstanding of 113.36 million shares for the year ending 2024.
- Evofem Biosciences, Inc. showed an increase of +466.6% in Common Stock Shares Outstanding from 2023 to 2024.
- This data is from Evofem Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 24, 2025.
- XBRL data for this metric is available from 2014 to 2024 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2014 to 2024), Evofem Biosciences, Inc.'s Common Stock Shares Outstanding has grown by 729.2%.
- Historical annual values: Fiscal year 2024: 113.36 million shares | Fiscal year 2023: 20.01 million shares | Fiscal year 2022: 984,786 shares | Fiscal year 2021: 10.83 million shares | Fiscal year 2020: 81.35 million shares | Fiscal year 2019: 48.14 million shares | Fiscal year 2018: 25.87 million shares | Fiscal year 2017: 2.08 million shares | Fiscal year 2016: 2.30 million shares | Fiscal year 2015: 13.75 million shares | Fiscal year 2014: 13.67 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: